title: Addition of clarithromycin to lenalidomide/low-dose dexamethasone was effective in a case of relapsed myeloma after long-term use of lenalidomide.
authors.affiliation: Department of Hematology and Rheumatology, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
authors.forename: Hiroki
authors.initials: H
authors.lastname: Kato
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Onishi
authors.forename: Yoko
authors.initials: Y
authors.lastname: Okitsu
authors.forename: Yuna
authors.initials: Y
authors.lastname: Katsuoka
authors.forename: Tohru
authors.initials: T
authors.lastname: Fujiwara
authors.forename: Noriko
authors.initials: N
authors.lastname: Fukuhara
authors.forename: Kenichi
authors.initials: K
authors.lastname: Ishizawa
authors.forename: Masanori
authors.initials: M
authors.lastname: Takagawa
authors.forename: Hideo
authors.initials: H
authors.lastname: Harigae
mesh_terms: D017291:Clarithromycin / Q000008:administration & dosage*; D003907:Dexamethasone / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D008875:Middle Aged; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy*; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000188:drug therapy*; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016896:Treatment Outcome
chemical_list: D013792:Thalidomide; D003907:Dexamethasone; D000077269:Lenalidomide; D017291:Clarithromycin